Axsome Therapeutics, Inc.
- AXSM
- NASDAQ
- Biotechnology
- CNS Disorder Therapeutics
- Biopharmaceuticals (Pipeline)
$156.04
Today −0.70%Quote Oct 19, 2026, 02:35 PM UTC
−26.67%over the last month
Max drawdown −27.0%From 1-month high −26.7%3 months −29.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$8.17B
Quote Oct 19
Next earnings
Nov 2
Expected, not confirmed
Analyst target
$283.00
+81.4% from here
Floor
$149.50
4.2% below price
Where the price sits
27 analysts
Analyst range, low to high
$246.00$380.00
- Price $156.04
- Resistance $157.81
- Consensus $283.00
The price is right under resistance. Analysts' average target sits about 81% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about AXSMPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $218.4M
- Product$216.4M99.1%
- Royalty$1.5M0.7%
Industry
Biotechnology
Employees
1,346